Corton Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,099
| Closed | -$283K | – | 591 |
|
|
2024
Q3 | $283K | Buy |
+5,099
| New | +$283K | 0.14% | 213 |
|
|
2023
Q4 | – | Sell |
-8,856
| Closed | -$316K | – | 636 |
|
|
2023
Q3 | $316K | Buy |
8,856
+2,794
| +46% | +$99.6K | 0.16% | 187 |
|
|
2023
Q2 | $280K | Buy |
+6,062
| New | +$280K | 0.13% | 230 |
|
|
2023
Q1 | – | Sell |
-6,017
| Closed | -$279K | – | 377 |
|
|
2022
Q4 | $279K | Buy |
+6,017
| New | +$279K | 0.23% | 141 |
|